We are significantly invested in the development of new products. Our domain is generic drugs, thanks to which we enable access to modern therapies for a wide group of researchers. We conduct our own research and development, and we cooperate with universities and research institutes abroad. We develop products in new, very advanced areas: dermatology, spirometry (asthma) and injectables (in both aqueous suspensions and oil based solution injectables).

Our procurement division sources API’s from industry leading manufacturers. We conduct our own analytics to independently verify quality and purity. Body Pharm maintains state-of-the-art laboratories equipped with advanced instrumentation and testing facilities. This empowers our scientists to evaluate the performance, stability, and release kinetics of various drug delivery systems. We conduct in vitro and in vivo studies to ensure the safety, reliability, and bioavailability of our formulations, paving the way for clinical translation. Our facility comprises of cutting edge analytical instrumentation namely HPLC and UHLPC and have having access to further instrumentation through our partner research institutes to HNMR/NMR to fully complete our data collection and analysis.

Our combined experience in pharmaceutical compounding allows us to further develop new products with various delivery systems. We have privately developed an array of hormone products with novel esters. With a deep commitment to advancing healthcare and improving patient outcomes, Body Pharm pioneers innovative solutions that enhance the effectiveness, safety, and convenience of hormone and ester-based therapies.